Jianing Mm Niu

Jianing Mm Niu

Auto-generated profile, based on publicly available information

Jianing Mm Niu

Department of Obstetrics and Gynecology, Jiaxing Maternity and Child Health Care Hospital, College of Medicine, Jiaxing University, Jiaxing, Zhejiang, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2024 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
JNJianing Niu
Jianing Niu
XTXiaoming Teng
Xiaoming Teng
JZJunyu Zhang
Junyu Zhang
Introduction: Wiedemann–Steiner syndrome (WSS) is a rare autosomal‐dominant disorder caused by KMT2A variants. The aim of this study was to characterize a novel KMT2A variant in a child with WSS and demonstrate integrated diagnostic approaches.Methods: A 3‐year‐old female with developmental delay, distinctive facial features, and anal fistula underwent whole exome sequencing (WES). RNA analysis was performed to assess splicing effects caused by a novel variant.Results: WES identified novel heterozygous KMT2A c.5664+6T>C variant initially classified as a variant of uncertain significance. RNA analysis provided evidence of aberrant splicing (exon 20 skipping), allowing reclassification to likely pathogenic. The patient exhibited typical WSS features along with a potential novel finding of anal fistula.Conclusion: This report describes a novel non‐canonical splice site variant in KMT2A associated with WSS. RNA analysis was critical for variant reclassification. Detailed phenotypic evaluation revealed common and expanded WSS manifestations. This case highlights the importance of combining clinical assessment, DNA testing, and RNA functional assays for the diagnosis of rare genetic disorders.

7 March 2025 in Medicine
Verified
Journal Article
Open access
TSTingting Mm Song
Tingting Mm Song
WZWeili Mm Zhu
Weili Mm Zhu
MWMeilin Wang
Meilin Wang
XLXiqing Mm Liu
Xiqing Mm Liu
YFYe Bd Feng
Ye Bd Feng
JNJianing Mm Niu
Jianing Mm Niu
Background: Assisted reproductive technology still presents a significant challenge when it comes to repeated implantation failure (RIF). To address this issue, personalized embryo transfer (pET) has been suggested as a potential solution. pET involves guiding the embryo transfer process based on an analysis of endometrial receptivity, known as endometrial receptivity analysis (ERA). However, the clinical value of this approach remains uncertain. Methods: We conducted a comprehensive analysis of 14 studies pertaining to pET guided by ERA in patients with RIF. The outcomes evaluated in these studies encompassed the clinical pregnancy rate (CPR), implantation rate, and live birth rate (LBR). In addition, we performed subgroup analysis by considering different definitions of RIF and utilizing various ERA techniques, such as traditional and optimized gene-enhanced approaches. Results: In general, the utilization of ERA-guided pET did not have a substantial impact on CPR (relative risk [RR], 1.25 [95% CI, 0.85–1.84]), implantation rate (RR, 1.59 [95% CI, 0.89–2.82]), or LBR (RR, 1.55 [95% CI, 0.96–2.50]) compared with standard transfer. However, the implementation of optimized gene-enhanced ERA methods demonstrated significant enhancements in CPR (RR, 2.04 [95% CI, 1.53–2.72]) and LBR (RR, 2.61 [95% CI, 1.58–4.31]). Conclusion: While ERA-guided pET shows limited efficacy in improving pregnancy outcomes in patients with RIF, there lies potential in optimizing gene-enhanced ERA techniques to augment both clinical pregnancy rates and LBRs.